Egle Jurgaityte is a Senior Research Associate in the Therapeutics/Development group focused on developing new cell therapies against our novel targets. Prior to joining Cartography, she was an undergraduate researcher at DuPage/Raulet labs at the University of California, Berkeley. Egle holds a B.A. in Molecular and Cell Biology from UC Berkeley. In her spare time, she enjoys surfing, hiking, and exploring new places.
Recent Posts
- Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
- Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens
- Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
- Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic
- Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team
Recent Comments
No comments to show.